ZHANG Shu-hua, RUAN You-bing, WU Zhong-bi, J. NKitinya, MA Yun, ZHU Yu-hong, LÜ Zeng-hua. Study on Histopathological Characteristics of Kaposi's Sarcoma[J].Chinese Journal of Dermatology, 2005, 38(1): 47-49.
[1] Simonart T, Hermans P, Schandene L, et al. Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaqueand nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Br J Dermatol, 2000, 143: 557-563. [2] Schwartz RA. Kaposi's sarcoma. Ann Transplant, 1998, 3: 5-12. [3] Hodak E, Hammel I, Feinmesser M, et al. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma.Am J Dermatopathol, 1999, 21: 138-145. [4] Polverini PJ, Nickoloff BJ. Role of scatter factor and the c-met protooncogene in the pathogenesis of AIDS-associated Kaposi's sarcoma. Adv Cancer Res, 1995,66: 235-253. [5] 张树华,阮幼冰,武忠弼,等.c-Met蛋白和c-Met mRNA在地方性和艾滋病相关性Kaposi肉瘤中的表达.中华皮肤科杂志,2003,36:574-576. [6] 张树华,阮幼冰,Kitinya JN,等.Kaposi肉瘤组织发生的研究.中国肿瘤临床,2003,30:540-543. [7] Fernandez-Figueras MT, Puig L, Penin RM, et al. Decreased immunoreactivity for cell-cycle regulator p27 (Kip 1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement. J Pathol, 2000, 191: 387-393. [8] Kaaya EE, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer, 1992, 28A: 1890-1894.